PRKAA2 and neoplasm: In an integrated metabolomics approach in HepG2 liver cancer cells, high dose of MTF mediated, under high glucose concentration, hypoglycemic effects, reduced tumor cell proliferation, and mediated apoptosis by activating AMPK/mTOR pathway signaling [85].